Qianjiang Yongan Pharmaceutical Co Ltd (002365) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥58.18 Million ≈ $8.51 Million USD) by net assets (CN¥2.02 Billion ≈ $294.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Qianjiang Yongan Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
Qianjiang Yongan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Qianjiang Yongan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Qianjiang Yongan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qianjiang Yongan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Qianjiang Yongan Pharmaceutical Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ceepower Co Ltd
SHE:300062
|
0.027x |
|
AQUILA PART PROD COM
RO:AQ
|
0.061x |
|
LG Balakrishnan & Bros Limited
NSE:LGBBROSLTD
|
0.063x |
|
Kimball Electronics
NASDAQ:KE
|
0.012x |
|
BGT Group Co. Ltd.
SHE:300774
|
N/A |
|
Cars.com Inc
NYSE:CARS
|
0.125x |
|
Changchun Gas Co Ltd
SHG:600333
|
-0.006x |
|
Impact Growth REIT
BK:IMPACT
|
0.021x |
Annual Cash Flow Conversion Efficiency for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024. View Qianjiang Yongan Pharmaceutical Co Ltd share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.04 Billion ≈ $298.82 Million |
CN¥105.71 Million ≈ $15.47 Million |
0.052x | -56.59% |
| 2023-12-31 | CN¥2.05 Billion ≈ $299.73 Million |
CN¥244.26 Million ≈ $35.74 Million |
0.119x | -35.25% |
| 2022-12-31 | CN¥2.10 Billion ≈ $307.74 Million |
CN¥387.28 Million ≈ $56.67 Million |
0.184x | +253.98% |
| 2021-12-31 | CN¥1.96 Billion ≈ $286.37 Million |
CN¥101.81 Million ≈ $14.90 Million |
0.052x | -54.34% |
| 2020-12-31 | CN¥1.81 Billion ≈ $265.42 Million |
CN¥206.66 Million ≈ $30.24 Million |
0.114x | -21.20% |
| 2019-12-31 | CN¥1.66 Billion ≈ $242.43 Million |
CN¥239.55 Million ≈ $35.05 Million |
0.145x | -26.06% |
| 2018-12-31 | CN¥1.61 Billion ≈ $235.00 Million |
CN¥314.02 Million ≈ $45.95 Million |
0.196x | +33.26% |
| 2017-12-31 | CN¥1.34 Billion ≈ $196.77 Million |
CN¥197.32 Million ≈ $28.87 Million |
0.147x | +104.33% |
| 2016-12-31 | CN¥1.18 Billion ≈ $172.25 Million |
CN¥84.53 Million ≈ $12.37 Million |
0.072x | +13.87% |
| 2015-12-31 | CN¥1.12 Billion ≈ $163.82 Million |
CN¥70.61 Million ≈ $10.33 Million |
0.063x | +262.73% |
| 2014-12-31 | CN¥1.11 Billion ≈ $162.12 Million |
CN¥19.26 Million ≈ $2.82 Million |
0.017x | -70.50% |
| 2013-12-31 | CN¥1.08 Billion ≈ $158.02 Million |
CN¥63.65 Million ≈ $9.31 Million |
0.059x | -8.84% |
| 2012-12-31 | CN¥1.09 Billion ≈ $160.11 Million |
CN¥70.75 Million ≈ $10.35 Million |
0.065x | -25.14% |
| 2011-12-31 | CN¥1.06 Billion ≈ $154.57 Million |
CN¥91.23 Million ≈ $13.35 Million |
0.086x | +98.86% |
| 2010-12-31 | CN¥1.01 Billion ≈ $148.46 Million |
CN¥44.06 Million ≈ $6.45 Million |
0.043x | -61.35% |
| 2009-12-31 | CN¥324.17 Million ≈ $47.44 Million |
CN¥36.43 Million ≈ $5.33 Million |
0.112x | -81.62% |
| 2008-12-31 | CN¥259.12 Million ≈ $37.92 Million |
CN¥158.47 Million ≈ $23.19 Million |
0.612x | +91.78% |
| 2007-12-31 | CN¥191.53 Million ≈ $28.03 Million |
CN¥61.08 Million ≈ $8.94 Million |
0.319x | +7.60% |
| 2006-12-31 | CN¥104.99 Million ≈ $15.36 Million |
CN¥31.11 Million ≈ $4.55 Million |
0.296x | -- |
About Qianjiang Yongan Pharmaceutical Co Ltd
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmace… Read more